Clinical Trial Update: Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib

View source ↗

Summary

This clinical trial update describes using continuous glucose monitoring to characterize and manage hyperglycemia in patients initiating alpelisib for metastati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Piqray (alpelisib)

Snippet

Sponsor: HealthPartners Institute | Conditions: Metastatic Breast Cancer | Status: ACTIVE_NOT_RECRUITING